|
1. |
Glomerulonephritis in South Africa |
|
Nephron,
Volume 60,
Issue 3,
1992,
Page 257-259
Y.K. Seedat,
Preview
|
PDF (708KB)
|
|
ISSN:1660-8151
DOI:10.1159/000186762
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
2. |
Tumoral Calcifications in Hemodialysis Patients: Possible Role of Aluminum Intoxication |
|
Nephron,
Volume 60,
Issue 3,
1992,
Page 260-267
Brigitte Zins,
Johanna Zingraff,
Carlo Basile,
Thierry Petitclerc,
Pablo Ureña,
Thomas Bardin,
Tilman Drüeke,
Preview
|
PDF (1502KB)
|
|
摘要:
Uremic patients may develop extraskeletal calcifications. Among the latter, periarticular tumoral calcifications (TC) represent massive, multiloculated calcium-phosphate deposits. The aim of this report was to analyze a series of 10 cases of TC in hemodialysis patients who were admitted at the Necker Hospital between 1974 and 1988. They were all male. An increased plasma calcium × phosphorus product was observed in 8 of the 10 patients. Plasma calcium level was increased in only 2 patients. In contrast, hyperphosphatemia was a constant feature in all the patients, as was the absence of an increase in plasma alkaline phosphatase activity. Using the bone histomorphometry technique, osteitis fibrosa of mild degree was observed in 2 patients, of moderate degree in 2 and of severe degree in 2 others. Evidence of aluminum (AT) overload was found in the 8 patients in whom it was searched based on bone histomorphometry, bone histochemistry, bone Al content and increased serum Al levels either in the basal state or after a deferoxamine test. In addition, Al overload was strongly suspected in the 2 remaining patients because of prolonged exposure to Al-contaminated dialysate. Various treatment strategies, including parathyroidectomy (PTx), were undertaken that remained unsuccessful in modifying the course of TC to a significant extent. Remarkably, TC occurred for the first time after PTx in 1 patient and worsened after PTx in 2 others. In conclusion, overt secondary hyperparathyroidism appears not to be an essential prerequisite for TC development in hemodialysis patients, and PTx must not be performed in such patients on the sole basis of the presence of TC. A preexisting Al intoxication and the attendant disturbances of bone mineralization could be directly or indirecty involved in the occurrence of TC. In addition, other factors must also play a role, the nature of which has still to be defined
ISSN:1660-8151
DOI:10.1159/000186763
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
3. |
Radiolucent Bone Cysts and the Type of Dialysis Membrane Used in Patients Undergoing Long-Term Hemodialysis |
|
Nephron,
Volume 60,
Issue 3,
1992,
Page 268-273
Yoshiaki Miura,
Takeshi Ishiyama,
Akira Inomata,
Tetsuro Takeda,
Seietsu Senma,
Koichiro Okuyama,
Yoshiki Suzuki,
Preview
|
PDF (1130KB)
|
|
摘要:
The relationship between the types of dialysis membrane used and the prevalence and severity of radiolucent bone cysts (which are a main radiological feature of dialysis amyloidosis) was studied in 30 patients on hemodialysis for more than 10 years. One of them was treated exclusively with cuprophane; the other 29 were dialyzed with cuprophane, and then treated with polyacrylonitrile AN 69. In 12 of the 30 patients, radiolucent bone cysts (at least 5 mm in diameter in the wrists and at least 10 mm in the shoulders or hips) were observed. The patients with bone cysts spent significantly more time on cuprophane dialysis and significantly less time on AN 69 dialysis than the group of patients without bone cysts. Nine of the 14 patients who had been treated with cuprophane for more than 8 years had bone cysts; whereas bone cysts were observed in only 2 of the 12 patients dialyzed for more than 8 years with AN 69. The frequency of bone cysts was significantly different for each of the two groups. There was, however, no significant difference in the total duration of dialysis between the two groups. The severity of the cystic bone lesions correlated positively with the duration of dialysis using cuprophane and negatively with the duration of dialysis using AN 69. These findings suggest that the development of osteoarticular amyloidosis may be related to the type of dialysis membrane used. Hemodialysis using AN 69 membranes may prevent, or at least postpone the development of dialysis amyloidosis.
ISSN:1660-8151
DOI:10.1159/000186764
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
4. |
Beta-2-Microglobulin-Derived Amyloidosis: Onset, Distribution and Clinical Features in 13 Hemodialysed Patients |
|
Nephron,
Volume 60,
Issue 3,
1992,
Page 274-280
G. Stein,
A. Schneider,
K. Thoss,
E. Ritz,
R.P. Linke,
K. Schaefer,
H. Sperschneider,
K. Abendroth,
R. Fünfstück,
Preview
|
PDF (1333KB)
|
|
摘要:
Postmortem examinations were carried out in 13 patients (6 males, 7 females, age 58 ± 9 years) who had been on regular hemodialysis treatment for 10-90 months using disposable regenerated cellulose membrane dialyzers. The prevalence of β2-microglobulin (β2m)-derived AB-amyloid deposits in different sites was determined. At autopsy, specimens were obtained from different joints, paravertebral tissue, intervertebral discs and from visceral organs. During life, routine laboratory parameters and radiographic studies had been carried out at 6-month intervals. Serum levels of β2m were elevated in all patients (57.5 ± 13.4 mg/l). Synovial AB-amyloid deposits were shown in different joints of 4 patients, aged between 59 and 73 years, and dialysed for 10-90 months, respectively. All had been unremarkable by X-ray and asymptomatic. No amyloid could be detected in the intervertebral discs of 2 further patients suffering from destructive spondylarthropathy. In 11 of the 13 patients, extracellular β2m deposits were observed by immunohistochemistry in different tissues. The results document that (a) AB-amyloidosis may occur in elderly patients even when dialysed for less than 5 years; (b) most cases are completely asymptomatic; the appearance of symptoms must be dependent on additional factors, e. g., site of AB-amyloid deposition and intensity of inflammatory reaction, and (c) AB-amyloid is not the exclusive cause of destructive spondylarthropathy, as 2 typical cases were observed who were devoid of am
ISSN:1660-8151
DOI:10.1159/000186765
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
5. |
Post-Obstruction Diuresis: Influence of Renal Prostaglandins |
|
Nephron,
Volume 60,
Issue 3,
1992,
Page 281-285
Michael L. Kauker,
Edward T. Zawada,
Preview
|
PDF (984KB)
|
|
摘要:
The possible role of altered renal prostaglandin metabolism in the generation of post-obstruction diuresis (POD) was examined in 16 adult male Sprague-Dawley rats. Inhibition of cyclooxygenase by the administration of a combination of two nonsteroidal anti-inflammatory drugs (NSAID), meclofenamate and indomethacin in 8 of these rats exaggerated, rather than lowered the degree of natriuresis and diuresis that followed the release 24 h after bilateral ureteral ligation. Urine osmolarity was similar in the two groups of rats treated with the NSAID and vehicle. The results suggest an enhanced synthesis of renal vasoconstrictor and antidiuretic prostaglandins (thromboxane A2 or PGF2α) during bilateral ureteral ligation. NSAIDs such as aspirin, indomethacin, meclofenamate and others may promote POD by blocking this prostaglandin pathway while promoting the cytochrome P450 monooxygenase pathway which may produce vasodilator, diuretic and natriuretic paracrine hormones. Additionally, inhibition of prostaglandin synthesis may have enhanced post-obstruction diuresis in the present studies by allowing a greater volume expansion during obstruction, as indicated by a reduced hematocrit in the rats that were pretreated with NSAID
ISSN:1660-8151
DOI:10.1159/000186766
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
6. |
Effect of 24,25- Dihydroxycholecalciferol on Intestinal Absorption of Calcium and Phosphate and on Parathyroid Hormone Secretion in Chronic Renal Failure |
|
Nephron,
Volume 60,
Issue 3,
1992,
Page 286-291
Z. Varghese,
J.F. Moorhead,
K. Farrington,
Preview
|
PDF (1198KB)
|
|
摘要:
Twelve patients with chronic renal failure (CRF) requiring dialysis, 7 of whom were hypercalcaemic, were treated with 24,25-dihydroxycholecalciferol [24,25(OH)2D3; 10 μg daily for 3 months] or placebo and the treatment then crossed over for a further 3 months. Treatment with 24,25(OH)2D3 was associated with small but significant increments in the fractional rates of absorption of calcium (p < 0.01) and phosphate (p < 0.05) measured by a combined radioisotope test, but even during treatment, the absorption of both calcium and phosphate remained subnormal. A significant fall in immunoreactive parathyroid hormone (i-PTH) levels occurred during treatment (p < 0.05) in the absence of significant changes in plasma ionised calcium and plasma phosphate levels. In 7 patients, treatment with 24,25(OH)2D3 50% suppression of i-PTH levels) at similar levels of ionised calcium. 24,25(OH)2D3 may have a role in the treatment of renal osteodystrophy, especially in patients with hypercalcaemic hyperparathyroidism
ISSN:1660-8151
DOI:10.1159/000186767
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
7. |
Heparin, Fatty Acids and Sodium, Potassium-ATPase Inhibition by Plasma Factors during Hemodialysis |
|
Nephron,
Volume 60,
Issue 3,
1992,
Page 292-301
M.H. Gault,
S.C. Vasdev,
L. Longerich,
L. Purchase,
C. Sampson,
E. Johnson,
Preview
|
PDF (2318KB)
|
|
摘要:
To assess the relationship between heparin and the associated increase in nonesterified fatty acids (NEFA) and their possible influence on NaK-ATPase during hemodialysis, we studied two groups of patients: (1) 12 patients on chronic hemodialysis dialysed with heparin and (2) 6 patients dialysed without heparin. All 12 patients who received heparin anticoagulation had a 7-fold rise in NEFA on average and also had an increase in circulating inhibitors of NaK-ATPase assayed by 3H-ouabain displacement from NaK-ATPase and/or by effect of plasma on the uptake of 86Rb by rat aortic rings. Serial assays in 3 of the patients receiving heparin showed NEFA and inhibitory changes to be at or near maximum within 30-60 min. Of the individual NEFA, the greatest relative increases were in oleic (18:1) and linoleic (18:2) acids, and the strongest correlations were between linoleic acid and both 3H-ouabain displacement (r = 0.94) and 86Rb uptake (r=0.86). However, a small and slower increase in NEFA also occurred in 3 of the patients dialysed without heparin. We conclude that heparin anticoagulation during dialysis leads to a rapid and marked increase in circulating NEFA, particularly the unsaturated fatty acids, with a corresponding interference with NaK-ATPase activity. The clinical significance of these findings is unknown. The rise in NEFA during dialysis without heparin in some patients suggests that factors other than heparin may also contribute to the rise in NEFA.
ISSN:1660-8151
DOI:10.1159/000186768
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
8. |
A Disease-Specific Questionnaire for Assessing Quality of Life in Patients on Hemodialysis |
|
Nephron,
Volume 60,
Issue 3,
1992,
Page 302-306
Andreas Laupacis,
Norman Muirhead,
Paul Keown,
Cindy Wong,
Preview
|
PDF (882KB)
|
|
摘要:
A disease-specific questionnaire was developed for patients receiving chronic hemodialysis by interviewing patients to determine which aspects of their quality of life were adversely affected by their disease. The final questionnaire contained 26 questions in five dimensions (physical symptoms, fatigue, depression, relationships with others, frustration). The questionnaire demonstrated construct validity when compared with the Sickness Impact Profile, time trade-off technique and an exercise stress test. It was reproducible in stable, placebo-treated patients (correlation coefficient 0.85-0.98 for the 5 dimensions). It was more responsive than other measures in detecting an improvement with erythropoietin therapy in a randomized, placebo-controlled trial. This questionnaire should be useful for the assessment of the effect of various interventions upon the quality of life of hemodialysis patients.
ISSN:1660-8151
DOI:10.1159/000186769
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
9. |
Serum Interleukin-6 in Long-Term Hemodialyzed Patients |
|
Nephron,
Volume 60,
Issue 3,
1992,
Page 307-313
Jean-Marc Cavaillon,
Jean-Louis Poignet,
Catherine Fitting,
Simone Delons,
Preview
|
PDF (1367KB)
|
|
摘要:
The generation of compounds such as interleukin 1 (IL-1), tumor necrosis factor alpha (TNFα), and the possible encounter of circulating cells with endotoxin (LPS) have been demonstrated during hemodialysis. All these factors are able to induce the production of IL-6 by human monocytes. Anaphylatoxins can be generated following complement activation by cellulosic membrane dialysis. C5a is known to potentiate the LPS-induced production of IL-1 and TNFα, and we established that recombinant human C5a was able to act synergistically with LPS in the induction of IL-6 by human monocytes. We investigated whether IL-6 could be detected in the serum of long-term hemodialyzed and uremic patients. Using the very sensitive 7TD1 cell line bioassay, we demonstrated that circulating IL-6 activity was present in the serum of all 14 tested patients, whereas it was occasionally present in normal sera. The presence of serum IL-6 was confirmed using an anti-IL-6 antibody and a specific ELISA (109 ± 36 pg/ml). Most patients had a reproducible level of IL-6 activity throughout a period of 10 days. The dialysis session did not significantly modify these levels and patients had similar serum IL-6 activity at the start, during or the at end of the dialysis session. The different parameters of the dialysis session (i.e. standard or filtrated dialyzates, complement-activating or nonactivating membranes) did not significantly influence the levels of IL-6. Elevated levels of IL-6 were also observed in uremic patients compared to normal donors, although significantly lower than in hemodialyzed patients (p = 0.001). Since IL-6 is a hepatocyte-stimulating mediator, we searched for a correlation with C-reactive protein (CRP). Although 4/14 hemodialyzed patients and 5/9 uremic patients had high CRP values, there was no correlation with IL-6 levels. Whether or not the hemodialysis itself or the pathology is responsible of the elevated level of IL-6 is discuss
ISSN:1660-8151
DOI:10.1159/000186770
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
10. |
Usefulness of the Assessment of Urinary Enzymes and Microproteins in Monitoring Ciclosporin Nephrotoxicity |
|
Nephron,
Volume 60,
Issue 3,
1992,
Page 314-318
G. Tataranni,
G. Zavagli,
R. Farinelli,
F. Malacarne,
O. Fiocchi,
L. Nunzi,
P. Scaramuzzo,
R. Scorrano,
Preview
|
PDF (957KB)
|
|
摘要:
The clinical usefulness of serial assays of urinary N-acetyl-β-D-glucosaminidase (NAG), γ-glutamyltransferase (GGT) and β2-microglobulin (β2M) were tested to evaluate and follow up the nephrotoxicity resulting from the prolonged administration of ciclosporin (CS). Three groups of patients were studied for 18 months: group A: functioning renal transplant patients (n = 13) on maintenance therapy from 12-31 months with CS and prednisone; group B: functioning renal transplant patients (n = ll) treated with prednisone and azathioprine; group C: patients (n = 10) affected by autoimmune steroid-unsensitive uveitis, free from previous renal disorder and treated with CS (for 8-16 months) at progressively decreasing doses. In groups A and B, the urinary enzymes and β2M underwent overlapping increases, so that these parameters cannot be considered reliable indices of CS-induced nephrotoxicity. This is due to the fact that transplanted kidneys are already altered by concomitant or preexisting affections, or by persistent immunologic injury. Conversely, in patients with uveitis, the serial assays of such urinary parameters prove to be quite reliable to evidence clinically yet unrecognizable kidney involvement due to prolonged CS administration. High enzymuria has been shown to be an earlier marker of nephrotoxicity only in nephropathy-free patients; on the other hand, the regression of elevated β2Muria into normal ranges indicates complete tubule cell rec
ISSN:1660-8151
DOI:10.1159/000186771
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
|